Who won the Patent war for Januvia, Glenmark or Merck?
Thinking that the battle is between Generic Vs innovator was only for anticancer and anti-retroviral medicines but now it has set a step into anti-diabetic drugs. The war is between Glenmark and Merk, the former has launched a cheaper generic version of an Anti-diabetic drug of pharma multinational Merck’s blockbuster anti-diabetes drug Januvia (Sitagliptin [...]





